TRIO expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.077200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.731700E-02
Normal-vs-Stage2
2.204800E-01
Normal-vs-Stage3
5.300500E-02
Normal-vs-Stage4
7.822600E-01
Stage1-vs-Stage2
5.368200E-01
Stage1-vs-Stage3
1.929390E-01
Stage1-vs-Stage4
4.235200E-01
Stage2-vs-Stage3
1.102590E-01
Stage2-vs-Stage4
3.910400E-01
Stage3-vs-Stage4
1.823240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.964400E-01
Normal-vs-AfricanAmerican
4.624800E-01
Normal-vs-Asian
1.254850E-01
Caucasian-vs-AfricanAmerican
6.227000E-01
Caucasian-vs-Asian
3.344200E-01
AfricanAmerican-vs-Asian
3.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.185600E-01
Normal-vs-Female
2.116200E-01
Male-vs-Female
7.396600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.606000E-01
Normal-vs-Age(41-60Yrs)
5.286200E-01
Normal-vs-Age(61-80Yrs)
1.243420E-01
Normal-vs-Age(81-100Yrs)
1.385350E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.379000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.492800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.612600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.967700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.230500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.441200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.352160E-01
Normal-vs-Daily Drinker
5.358300E-02
Normal-vs-Weekly Drinker
3.379000E-01
Normal-vs-Occasional Drinker
3.741600E-01
Normal-vs-Social Drinker
4.760000E-01
Non Drinker-vs-Daily Drinker
5.076800E-01
Non Drinker-vs-Weekly Drinker
2.832600E-01
Non Drinker-vs-Occasional Drinker
3.988800E-01
Non Drinker-vs-Social Drinker
1.416390E-01
Daily Drinker-vs-Weekly Drinker
9.761700E-02
Daily Drinker-vs-Occasional Drinker
1.723410E-01
Daily Drinker-vs-Social Drinker
4.253500E-02
Weekly Drinker-vs-Occasional Drinker
8.500400E-01
Weekly Drinker-vs-Social Drinker
7.217800E-01
Occasional Drinker-vs-Social Drinker
6.021000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.875200E-01
Normal-vs-Grade 2
8.512600E-01
Normal-vs-Grade 3
4.723800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.666200E-02
Grade 1-vs-Grade 3
2.962400E-02
Grade 1-vs-Grade 4
9.875200E-01
Grade 2-vs-Grade 3
3.096600E-01
Grade 2-vs-Grade 4
8.512600E-01
Grade 3-vs-Grade 4
4.723800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.057840E-01
Normal-vs-NonDiabetic
1.935000E-01
Diabetic-vs-NonDiabetic
4.018600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.702400E-01
Normal-vs-NoPancreatitis
1.763590E-01
Pancreatitis-vs-NoPancreatitis
5.707200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.591350E-01
Normal-vs-N1
2.449000E-01
N0-vs-N1
1.696450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.370000E-01
Normal-vs-TP53-NonMutant
1.106190E-01
TP53-Mutant-vs-TP53-NonMutant
6.268000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
